The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Four hepatic steatosis indices in predicting quantitative computed tomography-based metabolic dysfunction-associated fatty liver disease”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Mariusz Ciołkiewicz, Anna Kuryliszyn-Moskal, Ewa Jabłońska, Wioletta Ratajczak-Wrona, Jacek Janica, Włodzimierz Samborski, Piotr A. Klimiuk. Liver steatosis, selected organokines, and cardiovascular risk markers in rheumatoid arthritis, Frontiers in Endocrinology. 2026; 17: 1850882. https://doi.org/10.3389/fendo.2026.1850882 |
|
2 |
2025 |
Min-jun Kim, Jeonghyeon Kim, Inhwan Lee. Associations of Metabolic Dysfunction-Associated Fatty Liver Disease and Physical Activity with Knee Osteoarthritis in Middle-Aged and Older Women, Exercise Science. 2025; 34: 257. https://doi.org/10.15857/ksep.2025.00150 |
|
3 |
2026 |
Preeti Gupta, Ankita Rana, Durgesh Shukla, Vivek Gupta, Vineet V. Nair, Sangeeta Saxena, Anil Sharma, Ashok Sharma. Accuracy and Utility of Noninvasive Tools in Screening Adult Population for Hepatic Steatosis: A Validation Study in Southeast Rajasthan, CHRISMED Journal of Health and Research. 2026; 13: 36. https://doi.org/10.4103/cjhr.cjhr_132_25 |
|
4 |
2025 |
Mohamad Jamalinia, Samira Saeian, Nima Nikkhoo, Amirhossein Nazerian, Kamran Bagheri Lankarani. Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions, Metabolism and Target Organ Damage. 2025; 5: https://doi.org/10.20517/mtod.2025.131 |
|
5 |
2026 |
Elamin Abdelgadir, Fatheya Alawadi, Fauzia Rashid, Jörn M. Schattenberg, Alaaeldin Bashir. Risk of metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis: a large-scale study from the Middle East, International Journal of Obesity. 2026; https://doi.org/10.1038/s41366-026-02154-8 |